|
Re: Optimistic
|
|
Resverlogix Corp.
|
Oct 14, 2021 01:34PM
|
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
|
Resverlogix Corp.
|
Sep 04, 2018 05:51AM
|
|
Re: Optimistic
|
|
Resverlogix Corp.
|
Oct 19, 2021 08:46AM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
|
Zenith Epigenetics
|
Sep 04, 2018 05:52AM
|
|
Re: Key to an increased share price in the next 90 days
|
|
Resverlogix Corp.
|
Sep 30, 2019 04:25PM
|
|
Apabetalone May Repress Toxic Gene in Rare Muscular Dystrophy (FSHD)
|
|
Resverlogix Corp.
|
Sep 04, 2018 06:21AM
|
|
Re: Received a response....Third Eye Loan Balance
|
|
Resverlogix Corp.
|
Jul 14, 2019 05:20PM
|
|
Re: Key to an increased share price in the next 90 days
|
|
Resverlogix Corp.
|
Sep 30, 2019 04:39PM
|
|
Re: Reports of Exempt Distribution
|
|
Zenith Epigenetics
|
Feb 23, 2023 05:05PM
|
|
Re: Any day now......
|
|
Resverlogix Corp.
|
May 28, 2021 08:42PM
|
|
Re: New Share Price Contest
|
|
Resverlogix Corp.
|
Oct 12, 2019 07:12AM
|
|
Re: Additional Reports Of Exempt Distribution.
|
|
Zenith Epigenetics
|
Jun 06, 2024 08:28AM
|
|
Re: New SEDAR page
|
|
Zenith Epigenetics
|
Aug 03, 2023 11:06AM
|
|
Re: Providence Therapeutics
|
|
Resverlogix Corp.
|
Sep 14, 2021 04:04PM
|
|
Re: Warrants
|
|
Resverlogix Corp.
|
Feb 08, 2019 05:51AM
|
|
Re: RVX Long Covid Trial
|
|
Resverlogix Corp.
|
May 29, 2023 06:16AM
|
|
Re: Civil vs. criminal court judgments
|
|
Resverlogix Corp.
|
Dec 17, 2019 11:26AM
|
|
Re: find it interesting that RVXCF.....
|
|
Resverlogix Corp.
|
Nov 10, 2022 02:23PM
|
|
Re: if the partial sale of zen
|
|
Resverlogix Corp.
|
Aug 03, 2024 07:41PM
|
|
Re: Close competitor…
|
|
Resverlogix Corp.
|
Oct 19, 2021 09:43AM
|
